NCT02825706

Brief Summary

Although arthropathy is a serious problem in patients with hemophilia due to the associated morbidity and incapacity, to the best of the investigators knowledge, no studies have looked at the effect of educational physiotherapy for its clinical improvement. This contribution presents the results of educational physiotherapy program applied for 15 weeks with home exercises - in patients with hemophilic arthropathy. After treatment, experimental group showed improved a significant reduction of pain, and best quality of life al illness behaviour. During treatment no patient showed elbow haemarthrosis, which underlines the safety of this physiotherapy program.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2012

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 30, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 7, 2016

Completed
Last Updated

July 7, 2016

Status Verified

July 1, 2016

Enrollment Period

8 months

First QC Date

June 30, 2016

Last Update Submit

July 6, 2016

Conditions

Keywords

HemophiliaEducational PhysiotherapyPainQuality of lifeIllness BehaviourElbow

Outcome Measures

Primary Outcomes (5)

  • Change from baseline physical condition of joints after treatment and at 6 months

    The physical condition of joints was assessed using the Gilbert scale that measures swelling, muscle atrophy, joint crepitus, range of motion, axial deformity and instability. Scores range from 0 to 12 (0 represents no joint injury and 12 represents maximum joint deterioration).

    Screening visit, within the first seven days after treatment and after six months follow-up visit

  • Change from baseline joint pain after treatment and at 6 months

    Joint pain was assessed using the Visual Analog Scale (VAS), with scores ranging from 0 (no pain at all) to 10 (the worst pain imaginable by the patient).

    Screening visit, within the first seven days after treatment and after six months follow-up visit

  • Change from baseline perception of the quality of life after treatment and at 6 months

    The Haemophilia A-36 questionnaire was used to assess the perception of the quality of life. This questionnaire consists of 36 items that assess 9 domains (physical health, daily activities, joint damage and pain, treatment satisfaction, treatment difficulties, emotional functioning, mental health and social relationships).

    Screening visit, within the first seven days after treatment and after six months follow-up visit

  • Change from baseline illness behavior after treatment and at 6 months

    To assess illness behavior, patients completed the Illness Behavior Questionnaire (IBQ). This scale consists of 62 items and 8 domains (hypochondriasis, disease conviction, psychological vs. somatic perception of illness, affective inhibition, affective disturbance, denial and irritability).

    Screening visit, within the first seven days after treatment and after six months follow-up visit

  • Change from baseline frequency of bleedings after treatment and at 6 months

    The frequency of bleeding is measured with a record which complete the patients, where they indicate the incidence of hematomas and hemarthrosis during the treatment and follow-up.

    Screening visit, within the first seven days after treatment and after six months follow-up visit

Secondary Outcomes (4)

  • Radiological joint deterioration

    Screening visit

  • Age

    Screening visit

  • Weight

    Screening visit

  • Height

    Screening visit

Study Arms (2)

Experimental group

EXPERIMENTAL

The patients in experimental group received 60-minute educational sessions every two weeks about the pathophysiology of hemophilia, clinical manifestations, postural advice and prevention advice to avoid recurrent bleeding. Likewise, doubts on the clinical progress of hemophilic arthropathy, functional limitations and management of joint pain were resolved. In parallel with the educational sessions, patients followed a 15-week home exercise program performed once a day, 6 days a week. The program included muscle stretching exercises; isometric exercises; proprioceptive exercises on one leg with visual support; and a 20-minute walk. Low-intensity exercises with 20-25 repetitions were included.

Other: Educational physiotherapy group

Control group

NO INTERVENTION

The patients in the control group did not receive any educational sessions and did no exercise at all at home.

Interventions

20 patients with hemophilia were randomly allocated to an educational intervention or to a control group. The educational intervention was performed every two weeks during 15-week and home exercises were performed once a day, 6 days a week, in the same time

Experimental group

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with hemophilia A or B
  • Patients over 18 years
  • Patients with hemophilic arthropathy with at least 1 involved joint (elbow, knee or ankle)
  • having signed the informed consent document.

You may not qualify if:

  • Patients diagnosed with other congenital bleeding disorders (i.e. von Willebrand disease)
  • Patients who developed antibodies to FVIII or FIX (inhibitors)
  • Those not able to ambulate as a result of hemophilic arthropathy or any other disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hemophilia APainIllness Behavior

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Rubén Cuesta-Barriuso, PhD

    Real Fundación Victoria Eugenia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2016

First Posted

July 7, 2016

Study Start

February 1, 2012

Primary Completion

October 1, 2012

Study Completion

April 1, 2015

Last Updated

July 7, 2016

Record last verified: 2016-07

Data Sharing

IPD Sharing
Will not share